about
Mica Nanoparticle, STB-HO Eliminates the Human Breast Carcinoma Cells by Regulating the Interaction of Tumor with its Immune MicroenvironmentAutophagy-Dependent Secretion: Contribution to Tumor ProgressionIL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.Fever and the thermal regulation of immunity: the immune system feels the heat.Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities.Pharmacological inhibition of caspase-8 limits lung tumour outgrowth.Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanismAntitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.IL-6 Inhibition Reduces STAT3 Activation and Enhances the Antitumor Effect of Carboplatin.Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.Radon Exposure, IL-6 Promoter Variants, and Lung Squamous Cell Carcinoma in Former Uranium MinersBlockade of high mobility group box 1 augments antitumor T-cell response induced by peptide vaccination as a co-adjuvant.Tyrosine kinase LYN is an oncotarget in human cervical cancer: A quantitative proteomic based study.Selective depletion of cultured macrophages by magnetite nanoparticles modified with gelatin.IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.Role of interleukin-6 in cancer progression and therapeutic resistance.CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitroTocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cellsA time-series analysis of altered histone H3 acetylation and gene expression during the course of MMAIII-induced malignant transformation of urinary bladder cells.The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance.Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancerRole of liver ICAM-1 in metastasis.IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients.Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization within the Tumor Microenvironment Niche.Ferulic acid but not alpha-lipoic acid effectively protects THP-1-derived macrophages from oxidant and pro-inflammatory response to LPS.Differential effects on membrane permeability and viability of human keratinocyte cells undergoing very low intensity megasonic fields.Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy.Suppression of STAT3 NH2 -Terminal Domain Chemosensitizes Medulloblastoma Cells by Activation of Protein Inhibitor of Activated STAT3 via de-repression by MicroRNA-21.T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.The cryo-thermal therapy-induced IL-6-rich acute pro-inflammatory response promoted DCs phenotypic maturation as the prerequisite to CD4+ T cell differentiation.IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.Contribution of Adipose Tissue to Development of Cancer.Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines.
P2860
Q27304695-1613A633-0A67-4CC2-B886-31B6E9CD30F8Q28078649-134D0962-A26C-41A8-8B58-6D070CE8E6D4Q33772144-7883F7EF-4E41-441B-8770-37114301276CQ34476418-1D5694D8-CC92-4A24-8085-4E8AE1DCF0B5Q34586937-CDD3A5F5-1ECD-4A71-BB13-B3C6656DFDFDQ35911768-BF944BD7-A2F5-4439-938E-7E7A29DCB507Q36319849-C42F8FDA-0793-48CD-ABDC-6EEB692C4885Q36453386-D9AC8262-E200-4543-96B6-77D7C68C45A4Q36661347-A399AB28-181A-45AD-BE0F-E09D59221FD2Q36675086-42A25EA9-94E2-47D9-BC88-250A20B73532Q36793506-26A3FAD9-BD84-44F0-8E6E-B63BE59040B5Q37544372-FFE7369E-9A17-43FA-BC95-E2FB18F42B02Q37688964-6B7B63A5-655B-4FE8-AD9D-0824EDC29D20Q38694868-C3E3CABC-9C45-4B57-BB44-01A2026993BEQ38741339-63C58F3A-B11E-4C1A-99F9-4847AF8827A9Q38853625-74884698-1F6C-42F9-9247-10F7414D7DCEQ38867206-267BD807-47FE-4A4E-A1ED-985CDF7F559EQ38870044-E990CF9F-9C7B-44DF-8EFB-F0F29781A8BBQ38969931-0B66AF85-B047-4C11-AC39-07D1E31546ABQ39034031-0A5E9823-F461-4ED6-B11C-A00A256AFDE3Q39356609-5FEB6CDE-EC83-4F2D-930A-7E3B07A46EF4Q40348056-DFBCF0AF-83AB-4421-9298-C15E4F71DB0AQ40503359-0D582A53-5927-4849-ACB9-D0467A3962F8Q41143092-0127364D-C58A-403F-B7F2-C0582DA9ED11Q41701847-9B423A0A-A8EC-4387-BF1A-A0BC3BDF4CEBQ42139657-C350928A-60B5-4B18-B7F2-1A8F98C2D93EQ42358535-3243CD42-6452-4314-83C7-4D31C3D5271CQ42432514-AD7A17C5-BC3F-49EC-9682-25026571DC7DQ45913373-CD743310-18BE-43A9-A4EB-5A5526A447B8Q46312094-F3AC3978-AF5C-4CD3-B3D6-65D4F37604A6Q47139913-827C00F8-D32C-4660-8713-5505445D4332Q47209071-1D0AE88D-2C40-478E-9E00-CD1011F9EF66Q47252392-09CCABC0-7F93-42EA-9087-61261BC1E615Q47367610-EEE4182E-250C-4AA6-B2CB-7FDAB936FEB4Q47570404-4B41DA58-3991-452B-B50A-EAFF7CB51667Q47714445-B0CF1AE0-2C60-4C1E-B24D-084B234F34CCQ48764092-6B3E4E4B-7AFC-4DCA-A3FE-F91CA8B9F9DFQ49164235-71F19289-C0F6-4752-995A-3DC0938829A6Q49328492-CCD93B00-6BD9-4569-9308-8FDC5CB34D2AQ52558518-F96646EB-041D-4DF0-AA55-660D6C1C354A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The two faces of IL-6 in the tumor microenvironment.
@en
The two faces of IL-6 in the tumor microenvironment.
@nl
type
label
The two faces of IL-6 in the tumor microenvironment.
@en
The two faces of IL-6 in the tumor microenvironment.
@nl
prefLabel
The two faces of IL-6 in the tumor microenvironment.
@en
The two faces of IL-6 in the tumor microenvironment.
@nl
P2093
P2860
P1476
The two faces of IL-6 in the tumor microenvironment.
@en
P2093
Daniel T Fisher
Michelle M Appenheimer
Sharon S Evans
P2860
P356
10.1016/J.SMIM.2014.01.008
P577
2014-02-01T00:00:00Z